Thrivent Financial for Lutherans Increases Holdings in Doximity, Inc. (NASDAQ:DOCS)

Thrivent Financial for Lutherans boosted its position in shares of Doximity, Inc. (NASDAQ:DOCS) by 31.0% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 40,609 shares of the company’s stock after purchasing an additional 9,618 shares during the quarter. Thrivent Financial for Lutherans’ holdings in Doximity were worth $2,169,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds have also bought and sold shares of the company. Global Retirement Partners LLC lifted its position in shares of Doximity by 468.1% in the 4th quarter. Global Retirement Partners LLC now owns 534 shares of the company’s stock worth $29,000 after purchasing an additional 440 shares during the period. UMB Bank n.a. lifted its holdings in Doximity by 69.1% during the fourth quarter. UMB Bank n.a. now owns 575 shares of the company’s stock worth $31,000 after buying an additional 235 shares during the period. Larson Financial Group LLC boosted its position in Doximity by 49.4% during the 4th quarter. Larson Financial Group LLC now owns 756 shares of the company’s stock valued at $40,000 after acquiring an additional 250 shares in the last quarter. Morse Asset Management Inc bought a new stake in Doximity during the 3rd quarter valued at $46,000. Finally, IFP Advisors Inc raised its position in shares of Doximity by 344.1% in the 4th quarter. IFP Advisors Inc now owns 1,328 shares of the company’s stock worth $71,000 after acquiring an additional 1,029 shares in the last quarter. 87.19% of the stock is owned by institutional investors.

Doximity Trading Down 3.6 %

DOCS opened at $58.40 on Friday. The firm has a 50 day moving average of $65.48 and a two-hundred day moving average of $54.30. The firm has a market capitalization of $10.90 billion, a PE ratio of 58.40, a P/E/G ratio of 4.10 and a beta of 1.34. Doximity, Inc. has a 12-month low of $22.96 and a 12-month high of $85.21.

Insider Buying and Selling

In related news, Director Timothy S. Cabral sold 20,000 shares of the firm’s stock in a transaction dated Monday, February 3rd. The stock was sold at an average price of $57.62, for a total transaction of $1,152,400.00. Following the sale, the director now directly owns 6,360 shares of the company’s stock, valued at $366,463.20. This trade represents a 75.87 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. 37.40% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

Several research firms have issued reports on DOCS. Leerink Partners upgraded Doximity from a “market perform” rating to an “outperform” rating and lifted their target price for the company from $60.00 to $90.00 in a research note on Friday, February 7th. Mizuho lifted their price objective on shares of Doximity from $55.00 to $65.00 and gave the stock a “neutral” rating in a research report on Monday, February 10th. Wells Fargo & Company reissued an “equal weight” rating on shares of Doximity in a research report on Friday, February 7th. The Goldman Sachs Group lifted their price target on shares of Doximity from $58.00 to $80.00 and gave the stock a “neutral” rating in a report on Monday, February 10th. Finally, Bank of America increased their price objective on Doximity from $54.00 to $57.00 and gave the company a “neutral” rating in a report on Monday, January 6th. Eleven analysts have rated the stock with a hold rating, eight have assigned a buy rating and two have issued a strong buy rating to the company. According to MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $64.22.

About Doximity

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.